Acutaas Chemicals Ltd

NSE: ACUTAAS · BSE: 543349 · Pharmaceuticals & Biotechnology · 14 announcements

Share price: ₹3,272.50
Market cap: ₹26,792 Cr
Revenue (annual): ₹1,339 Cr
Net profit (annual): ₹356.3 Cr
P/E (TTM): 69.4×Sector 50.4×
Promoter holding: 32.66%+0.00% QoQ
FII holding: 21.61%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Earnings Call 6 Financial Results 2 Patent 1 Merger & Restructuring 1 Management Change 1 Capacity Expansion 1 Annual General Meeting 1 Acquisition 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

26 Sep 2026 19:20 IST BSE

Management Change

Acutaas Chemicals Management Change

Acutaas Chemicals Limited has announced the re-appointment of Ram Mohan Lokhande as Executive Director and Anita Bandyopadhyay as Non-Executive Independent Director for a 60-month term.

Read the filing ↗